ChemoCentryx is a startup based in the United States, most recent round Series-c-plus.
Based in the United States, ChemoCentryx is a startup. Its most recent tracked round is Series-c-plus.
ChemoCentryx is a U.S. drug-development company focused on discovering and developing therapeutics for inflammatory diseases. The company was listed on NASDAQ in 2012.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.